Biologics Consulting
Christopher Bussineau is a seasoned professional in the biotechnology and biopharmaceutical industries, currently serving as Principal Consultant at Biologics Consulting Group since January 2015. Previous roles include Officer at CB BioConsulting, Vice President of Operations at One Lambda, Inc. and BioVascular, Inc., as well as Vice President and General Manager at Cambrex Bio Science Baltimore. Christopher also held the position of Senior Director of Technical Operations at Chiron, a key player in the biotech revolution, and contributed as a Staff Scientist at Salk Institute Biotechnology/Industrial Associates. Christopher holds a PhD in Chemical Engineering from Rice University and a BA in Chemistry from UC San Diego, with earlier education in Biology at San Diego State University.
This person is not in any offices
Biologics Consulting
ABOUT Biologics Consulting is a complete FDA regulatory and product development consulting firm for cell & gene therapy, biologics, pharmaceuticals, and medical devices. In the nearly three decades since its founding, Biologics Consulting has become the go-to consulting partner for companies large and small seeking to bring innovative, safe, and effective products to market in the US. Our team of consultants and professional services staff is comprised of subject-matter experts with decades of industry and/or FDA experience that allows us to provide an unparalleled insider perspective. OUR DIFFERENCE The Biologics Consulting difference is all about the unique combination of expertise we have under one roof. Our team has depth of knowledge and breadth of experience across all product types and development pathways. This value proposition allows us to address the full scope of a client’s regulatory and product development challenges. OUR EXPERIENCE AREAS - Biologics - Medical Devices - Pharmaceuticals - Biosimilars OUR SERVICES - CONSULTING – Regulatory, Product Development, Clinical Planning and Quality support. - SUPPORT SERVICES – Medical Writing, ePublishing & Submissions, US Agent Services, Due Diligence OUR CLIENTS Our clients span the industry, from established multi-national pharmaceutical, biotechnology, and medical device companies to academic and research institutions. We also support small biotech and medical device start-ups. Since our founding, we have professionally services over 4,500 clients from 58 different countries.